Laboratorios Farmaceúticos Rovi SA (ROVI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Laboratorios Farmaceúticos Rovi SA (ROVI)
Company Performance

Current Price

as of Oct 23, 2024

$82.11

P/E Ratio

23.15

Market Cap

$4.15B

Description

Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.

Metrics

Overview

  • HQMadrid, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerROVI
  • Price$82.105172-1.31%

Trading Information

  • Market Cap$4.15B
  • Float36.11%
  • Average Daily Volume (1m)64,149
  • Average Daily Volume (3m)74,135
  • EPS$3.29

Company

  • Revenue$829.51M
  • Rev Growth (1yr)1.44%
  • Net Income$170.33M
  • Gross Margin55.95%
  • EBITDA Margin29.39%
  • EBITDA$243.80M
  • EV$3.16B
  • EV/Revenue3.81
  • P/E23.15
  • P/S4.75
  • P/B7.31